Cardinal Health Profit Margin 2006-2018 | CAH

Current and historical gross margin, operating margin and net profit margin for Cardinal Health (CAH) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Cardinal Health net profit margin as of December 31, 2018 is -0.03%.
Cardinal Health Annual Profit Margins
Cardinal Health Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $13.709B $136.809B
Cardinal Health, Inc. is a global, integrated healthcare services and products company, providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices worldwide. The company provides clinically proven medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency from hospital to home. Cardinal Health connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination and better patient management.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $61.317B 20.37
Align Technology (ALGN) United States $22.518B 57.33
McKesson (MCK) United States $21.887B 8.52
AmerisourceBergen (ABC) United States $15.293B 11.09
Laboratory Of America Holdings (LH) United States $14.330B 13.18
Cooper (COO) United States $13.885B 24.22
DENTSPLY SIRONA (XRAY) United States $11.127B 24.74
Henry Schein (HSIC) United States $9.192B 14.86
West Pharmaceutical Services (WST) United States $8.223B 39.69
Merit Medical Systems (MMSI) United States $3.170B 34.12
CONMED (CNMD) United States $2.242B 36.43
Patterson (PDCO) United States $2.031B 16.05
Atrion (ATRI) United States $1.612B 47.31
STAAR Surgical (STAA) United States $1.380B 115.59
Antares Pharma (ATRS) United States $0.437B 0.00
Invacare (IVC) United States $0.222B 0.00
Lifevantage (LFVN) United States $0.158B 21.27
Pro-Dex (PDEX) United States $0.063B 28.64
Endologix (ELGX) United States $0.060B 0.00
Biolase (BIOL) United States $0.049B 0.00